• Pelchat ML. You can teach an old dog new tricks: olfaction and responses to novel foods by the elderly. Appetite 2000; 35(2):153-60
• Graziadei PP. Cell dynamics in the olfactory mucosa. Tissue Cell 1973;5(1): 113-31
• Rawson NE, Gomez G, Cowart B et al. Selectivity and response characteristics of human olfactory neurons. J Neurophysiol 1997;77(3):1606-13
• Nibu K, Li G, Zhang X et al. Olfactory neuron-specific expression of NeuroD in mouse and human nasal mucosa. Cell Tissue Res 1999;298(3):405-14
• Gomez G, Rawson NE, Hahn CG, Michaels R, Restrepo D. Characteristics of odorant elicited calcium changes in cultured human olfactory neurons. J Neurosci Res 2000;62(5):737-49
• Schild D, Restrepo D. Transduction mechanisms in vertebrate olfactory receptor cells. Physiol Rev 1998;78(2): 429-66
• Yamagishi M, Ishizuka Y, Seki K. Pathology of olfactory mucosa in patients with Alzheimer’s disease. Ann Otol Rhinol Laryngol 1994 Jun;103(6):421-7
• Astic L, Saucier D. Neuronal plasticity and regeneration in the olfactory system of mammals: morphological and functional recovery following olfactory bulb deafferentation. Cell Mol Life Sci 2001;58(4):538-45
• Costanzo RM. Regeneration of olfactory receptor cells. Ciba Found Symp 1991;160:233-42
• Schwob JE. Neural regeneration and the peripheral olfactory system. Anat Rec 2002;269(1):33-49
• Federico G, Maremmani C, Cinquanta L, Baroncelli GI, Fattori B, Saggese G. Mucus of the human olfactory epithelium contains the insulin-like growth factorI system which is altered in some neurodegenerative diseases. Brain Res 1999;835(2):306-14
• Amoore JE. Specific anosmia: a clue to the olfactory code. Nature 1967;214(93): 1095-8
• Talamo BR, Rudel R, Kosik KS et al. Pathological changes in olfactory neurons in patients with Alzheimer‘s disease. Nature 1989;337(6209):736-9
• Rawson NE. Gomez G Cell and molecular biology of human olfaction. Microsc Res Tech 2002;58(3):142-51
• Amoore JE. Evidence for the chemical olfactory code in man.Ann N Y Acad Sci 1974;237(0):137-43
• Menashe I, Man O, Lancet D, Gilad Y. Different noses for different people. Nat Genet 2003;34(2):143-4
• Wysocki CJ, Dorries KM. Beauchamp GK Ability to perceive androstenone can be acquired by ostensibly anosmic people. Proc Natl Acad Sci U S A 1989;86(20): 7976-8
• Beauchamp GK, Yamazaki K. Chemical signalling in mice. Biochem Soc Trans 2003;31(Pt 1):147-51
• Deems DA, and Doty RL. Age-related changes in the phenyl ethyl alcohol odor detection threshold. Trans Pa Acad Ophthalmol Otolaryngol 1987;39(1):646- 50
• Wysocki CH, Gilbert AN. National Geographic Smell Survey. Effects of age are heterogenous. Ann N Y Acad Sci 1989;561:12-28
• Rawson NE, Gomez G, Cowart B, Restrepo D. The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases.Ann N Y Acad Sci 1998;855: 701-7
• Loo AT, Youngentob SL, Kent PF, Schwob JE. The aging olfactory epithelium: neurogenesis, response to damage, and odorant-induced activity. Int J Dev Neurosci 1996;14(7-8):881-900
• Ansari KA, Johnson A. Olfactory function in patients with Parkinson’s disease. J Chronic Dis 1975;28(9):493-7
• Waldton S. Clinical observations of impaired cranial nerve function in senile dementia. Acta Psychiatr Scand 1974;50(5):539-47
• Koss E, Weiffenbach JM, Haxby JV, Friedland RP. Olfactory detection and identification performance are dissociated in early Alzheimer’s disease. Neurology 1988;38(8):1228-32
• Morgan CD, Nordin S, Murphy C. Odor identification as an early marker for Alzheimer’s disease: impact of lexical functioning and detection sensitivity. J Clin Exp Neuropsychol 1995;17(5):793- 803
• Murphy C, Gilmore MM, Seery CS, Salmon DP, Lasker BR. Olfactory thresholds are associated with degree of dementia in Alzheimer’s disease. Neurobiol Aging 1990 Jul-Aug;11(4):465-9
• Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol 1987 Oct;44(10):1030-2
• Korten JJ, Meulstee J. Olfactory disturbances in Parkinsonism. Clin Neurol Neurosurg 1980;82(2):113-8
• Doty RL, Deems DA, Stellar S. Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology 1988;38(8):1237-44
• Moberg PJ, Pearlson GD, Speedie LJ, Lipsey JR, Strauss ME, Folstein SE. Olfactory recognition: differential impairments in early and late Huntington’s and Alzheimer’s diseases. J Clin Exp Neuropsychol 1987;9(6):650-64
• Razani J, Murphy C, Davidson TM, Grant I, McCutchan A. Odor sensitivity is impaired in HIV-positive cognitively impaired patients. Physiol Behav 1996 ;59(4-5):877-81
• Hornung DE, Kurtz DB, Bradshaw CB et. The olfactory loss that accompanies an HIV infection. Physiol Behav 1998;64(4): 549-56
• Lee JH, Goedert M, Hill WD, Lee VM, Trojanowski JQ. Tau proteins are abnormally expressed in olfactory epithelium of Alzheimer patients and developmentally regulated in human fetal spinal cord. Exp Neurol 1993;121(1):93- 105
• Crino PB, Martin JA, Hill WD, Greenberg B, Lee VM, Trojanowski JQ. BetaAmyloid peptide and amyloid precursor proteins in olfactory mucosa of patients with Alzheimer’s disease, Parkinson’s disease, and Down syndrome. Ann Otol Rhinol Laryngol 1995;104(8):655-61
• Yamagishi M, Ishizuka Y, Seki K. Definitive diagnosis of Alzheimer’s disease using olfactory mucosal biopsy. Nippon Jibiinkoka Gakkai Kaiho 1994 ;97(1):51-60
• Herve D, Levi-Strauss M, Marey-Semper I et al. G(olf) and Gs in rat basal ganglia: possible involvement of G(olf) in the coupling of dopamine D1 receptor with adenylyl cyclase. J Neurosci 1993;13(5): 2237-48
• Berkowicz DA, Trombley PQ. Dopaminergic modulation at the olfactory nerve synapse. Brain Res 2000;855(1):90- 9
• Trombley PQ, Shepherd GM. Synaptic transmission and modulation in the olfactory bulb. Curr Opin Neurobiol 1993;3(4):540-7
• Vargas G, Lucero MT. Dopamine modulates inwardly rectifying hyperpolarization-activated current (Ih) in cultured rat olfactory receptor neurons. J Neurophysiol 1999;81(1):149-58
• Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci 1999;168(2):127-30
• Zorzon M, Ukmar M, Bragadin LM et al. Olfactory dysfunction and extent of white matter abnormalities in multiple sclerosis: a clinical and MR study. Mult Scler 2000;6(6):386-90
• Davidson TM, Freed C, Healy MP, Murphy C. Rapid clinical evaluation of anosmia in children: the Alcohol Sniff Test. Ann N Y Acad Sci 1998;855:787-92
• Murphy C and Jinich S Olfactory dysfunction in Down’s Syndrome. Neurobiol Aging 1996;17(4):631-7
• Doty RL, Li C, Mannon LJ, Yousem DM Olfactory dysfunction in multiple sclerosis.N Engl J Med 1997;336(26): 1918-9
• Doty RL, Li C, Mannon LJ, Yousem DM., Olfactory dysfunction in multiple sclerosis: relation to longitudinal changes in plaque numbers in central olfactory structures. Neurology 1999;53(4):880-2
• Zivadinov R, Zorzon M, Monti Bragadin L, Pagliaro G, Cazzato G. Olfactory loss in multiple sclerosis. J Neurol Sci 1999 ;168(2):127-30
• Doty RL, Li C, Mannon LJ, Yousem DM. Olfactory dysfunction in multiple sclerosis. Relation to plaque load in inferior frontal and temporal lobes. Ann N Y Acad Sci 1998;855:781-6
• Yee KK, Rawson NE. Retinoic acid enhances the rate of olfactory recovery after olfactory nerve transsection. Brain Res Dev Brain Res 2000;124:129-32
• Englund U, Bjorklund A, Wictorin K.Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult rat brain. Brain Res Dev Brain Res 2002;134(1-2): 123-41
• Fricker RA, Carpenter MK, Winkler C, Greco C, Gates MA, Bjorklund A. Site-specific migration and neuronal differentiation of human neural progenitor cells after transplantation in the adult rat brain. J Neurosci 1999;19(14):5990-6005
• Brody D, Adler LA, Kim T, Angrist B, Rotrosen J. Effects of buspirone in seven schizophrenic subjects. J Clin Psychopharmacol 1990;10(1):68-9
• Hornung DE, Kurtz DB, Bradshaw CB et al. The olfactory loss that accompanies an HIV infection. Physiol Behav 1998;64(4): 549-56
• Razani J, Murphy C, Davidson TM, Grant I, McCutchan A. Odor sensitivity is impaired in HIV-positive cognitively impaired patients. Physiol Behav 1996 ;59(4-5):877-81
• Serby MJ, Larson PM, Kalkstein D. Olfaction and neuropsychiatry In: Serby, MJ. Chobor KL eds. Science of Olfaction. New York: Springer-Verlag; 1992:559- 584
• Heald AE, Schiffman SS. Taste and smell. Neglected senses that contribute to the malnutrition of AIDS. N C Med J 1997 ;58(2):100-4
• Ahlskog JE, Waring SC, Petersen RC et al. Olfactory dysfunction in Guamanian ALS, parkinsonism, and dementia. Neurology 1998;51(6):1672-7
• Adler CH, Gwinn KA, Newman S. Olfactory function in restless legs syndrome. Mov Disord 1998;13(3):563-5
• Doty RL, Bromley SM, Stern MB. Olfactory testing as an aid in the diagnosis of Parkinson’s disease: development of optimal discrimination criteria. Neurodegeneration 1995;4(1):93-7
• Wszolek ZK, Markopoulou K. Olfactory dysfunction in Parkinson’s disease. Clin Neurosci 1998;5(2):94-101
• Hawkes CH, Shephard BC, Daniel SE. Is Parkinson’s disease a primary olfactory disorder? QJM 1999;92(8):473-80
• Parati EA, Bez A, Ponti D, Sala S, Pozzi S, Pagano SF. Neural stem cells. Biological features and therapeutic potential in Parkinson’s disease. J Neurosurg Sci 2003 ;47(1):8-17
• Doty RL, Golbe LI, McKeown DA, Stern MB, Lehrach CM, Crawford D. Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson’s disease. Neurology 1993 ;43(5):962-5
• Sobel N, Thomason ME, Stappen I et al. An impairment in sniffing contributes to the olfactory impairment in Parkinson’s disease. Proc Natl Acad Sci U S A 2001 ;98(7):4154-9
• Tissingh G, Berendse HW, Bergmans P et al. Loss of olfaction in de novo and treated Parkinson’s disease: possible implications for early diagnosis. Mov Disord 2001;16(1):41-6
• Wilson DA, Sullivan RM. The D2 antagonist spiperone mimics the effects of olfactory deprivation on mitral/tufted cell odor response patterns. J Neurosci 1995; 15:5574-81
• Reuber M, Al-Din AS, Baborie A, Chakrabarty A. New variant CreutzfeldtJakob disease presenting with loss of taste and smell. J Neurol Neurosurg Psychiatry 2001;71(3):412-3
• Zanusso G, Ferrari S, Cardone F et al. Detection of pathologic prion protein in the olfactory epithelium in sporadic Creutzfeldt-Jakob disease .N Engl J Med 2003;348(8):711-9
• Nordin S, Paulsen JS, Murphy C. Sensory- and memory-mediated olfactory dysfunction in Huntington’s disease.J Int Neuropsychol Soc 1995;1(3):281-90
• Winkler S, Garg AK. Mekayarajjananonth T, Bakaeen LG, Khan E. Depressed taste and smell in geriatric patients. J Am Dent Assoc 1999;130(12):1759-65
• Spielman AI. Chemosensory function and dysfunction Crit Rev Oral Biol Med 1998;9(3):267-91
• Bromley SM. Smell and taste disorders: a primary care approach. Am Fam Physician 2000;61(2):427-36
• Schiffman SS. Taste and smell in disease (second of two parts). N Engl J Med 1983 ;308(22):1337-43
• Hoffman HJ, Ishii EK, MacTurk RH. Age-related changes in the prevalence of smell/taste problems among the United States adult population. Results of the 1994 disability supplement to the National Health Interview Survey (NHIS). Ann N Y Acad Sci 1998;855:716-22
• Heald AE, Pieper CF, Schiffman SS. Taste and smell complaints in HIV-infected patients 1998;12(13):1667-74
• Graham CS, Graham BG, Bartlett JA, Heald AE. Schiffman SS. Taste and smell losses in HIV infected patients. Physiol Behav 1995;58(2):287-93
• Menalled LB, Sison JD, Dragatsis I, Zeitlin S, Chesselet MF. Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington’s disease with 140 CAG repeats. J Comp Neurol 2003;465(1):11- 26
• Nijjar RK, Murphy C. Olfactory impairment increases as a function of age in persons with Down syndrome Neurobiol Aging 2002;23(1):65-73
• Bacon Moore AS, Paulsen JS, Murphy C. A test of odor fluency in patients with Alzheimer’s and Huntington’s disease. J Clin Exp Neuropsychol 1999;21(3):341- 51
• Murphy C. Loss of olfactory function in dementing disease. Physiol Behav 1999 ;66(2):177-82
• Arnold SE, Smutzer GS, Trojanowski JQ, Moberg PJ. Cellular and molecular neuropathology of the olfactory epithelium and central olfactory pathways in Alzheimer’s disease and schizophrenia. Ann N Y Acad Sci 1998;855:762-75
• Rawson NE, and et al unpublished data
• Doty RL Olfaction. Annual Review of Psychology 2001;52: 423-52
• Holcomb JD, Mumm JS, Calof AL. Apoptosis in the neuronal lineage of the mouse olfactory epithelium: regulation in vivo and in vitro. Dev Biol 1995;172(1): 307-23
• Zhainazarov AB, Doolin R, Herlihy JD, Ache BW. Odor-stimulated phosphatidylinositol 3-kinase in lobster olfactory receptor cells. J Neurophysiol 2001;85(6):2537-44
• Berendse HW, Booij J, Francot CM et al. Subclinical dopaminergic dysfunction in asymptomatic Parkinson’s disease patients’ relatives with a decreased sense of smell. Ann Neurol 2001;50(1):34-41
• Coronas V, Feron F, Hen R, Sicard G, Jourdan F. Moyse E- In vitro induction of apoptosis or differentiation by dopamine in an immortalized olfactory neuronal cell line. J Neurochem 1997;69(5):1870-81
• Koster NL, Norman AB, Richtand NM et al. Olfactory receptor neurons express D2 dopamine receptors. J Comp Neurol 1999 ;411(4):666-73
• Wilkie FL, Goodkin K, Khamis I et al. Cognitive Functioning in Younger and Older HIV-1-Infected Adults. J Acquir Immune Defic Syndr 2003;33(2):S93- S105
• Huang H, Chen L, Wang H et al. Influence of patients’ age on functional recovery after transplantation of olfactory ensheathing cells into injured spinal cord injury. Chin Med J (Engl) 2003;116(10): 1488-91
• Resnick DK, Cechvala CF, Yan Y, Witwer BP, Sun D, Zhang S. Adult olfactory ensheathing cell transplantation for acute spinal cord injury. J Neurotrauma 2003 ;20(3):279-85
• Parent JM. Injury-induced neurogenesis in the adult mammalian brain. Neuroscientist 2003;9(4):261-72
• Arlotta P, Magavi SS, Macklis JD. Induction of adult neurogenesis: molecular manipulation of neural precursors in situ. Ann N Y Acad Sci 2003;991:229-36
• Walker JC, Hall SB, Walker DB, KendalReed MS, Hood AF, Niu XF. Human odor detectability: new methodology used to determine threshold and variation. Chem Senses 2003;28(9):817-26
• Angioy AM, Desogus A, Barbarossa IT, Anderson P, Hansson BS. Extreme sensitivity in an olfactory system. Chem Senses 2003;28(4):279-84
• Lowe G, Nakamura T, Gold GH. Adenylate cyclase mediates olfactory transduction for a wide variety of odorants. Proc Natl Acad Sci U S A 1989;86(14):5641-5
• Ohta Y, Ichimura K. Changes in epidermal growth factor receptors in olfactory epithelium associated with aging. Ann Otol Rhinol Laryngol 2000;109(1):95-8
• Loo AT, Youngentob SL, Kent PF, Schwob JE. The aging olfactory epithelium: neurogenesis, response to damage, and odorant-induced activity. Int J Dev Neurosci 1996;14(7-8):881-900
• McCaffrey RJ, Duff K, Solomon GS. Olfactory dysfunction discriminates probable Alzheimer’s dementia from major depression: a cross-validation and extension. J Neuropsychiatry Clin Neurosci 2000;12(1):29-33
• Rezek DL. Olfactory deficits as a neurologic sign in dementia of the Alzheimer type. Arch Neurol 1987 ;44(10):1030-2
• Warner MD, Peabody CA, Flattery JJ, Tinklenberg JR. Olfactory deficits and Alzheimer’s disease. Biol Psychiatry 1986 ;21(1):116-8
• Thesen T, Murphy C. Age-related changes in olfactory processing detected with olfactory event-related brain potentials using velopharyngeal closure and natural breathing. Int J Psychophysiol 2001;40(2):119-27
• Mesholam RI, Moberg PJ, Mahr RN, Doty RL. Olfaction in neurodegenerative disease: a meta-analysis of olfactory functioning in Alzheimer’s and Parkinson’s diseases.Arch Neurol 1998;55(1):84-90
• Reyes PF, Deems DA, Suarez MG. Olfactory-related changes in Alzheimer’s disease: a quantitative neuropathologic study. Brain Res Bull 1993;32(1):1-5
• Trombley PQ, Shepherd GM. Synaptic transmission and modulation in the olfactory bulb. Curr Opin Neurobiol 1993; 3:540-7
• Brunig I, Sommer M, Hatt H et al. Dopamine receptor subtypes modulate olfactory bulb gamma-aminobutyric acid type A receptors. Proc Natl Acad Sci U S A 1999;96:2456-60
• DeHamer MK, Guevara JL, Hannon K et al. Genesis of olfactory receptor neurons in vitro: regulation of progenitor cell divisions by fibroblast growth factors. Neuron 1994;13:1083-97
• Calof AL, Mumm JS, Rim PC et al. The neuronal stem cell of the olfactory epithelium. J Neurobiol 1998;36:190-205
• Calof AL, Bonnin A, Crocker C et al. Progenitor cells of the olfactory receptor neuron lineage. Microsc Res Tech 2002; 58:176-88
• Huard JM, Youngentob SL, Goldstein BJ et al. Adult olfactory epithelium contains multipotent progenitors that give rise to neurons and non-neural cells. J Comp Neurol 1998;400:469-86
• Thibault O, Hadley R, Landfield PW Elevated postsynaptic Ca2+ i and Ltype calcium channel activity in aged hippocampal neurons: relationship to impaired synaptic plasticity. J Neurosci 2001;21(24):9744-56
• Tanaka Y, Ando S. Age-related changes in the subtypes of voltage-dependent calcium channels in rat brain cortical synapses. Neurosci Res 2001;39(2):213- 20
• Palego L, Giromella A, Mazzoni MR et al. Gender and age-related variation in adenylyl cyclase activity in the human prefrontal cortex, hippocampus and dorsal raphe nuclei. Neurosci Lett 2000;279(1): 53-6
• Rawson NE, Gomez G, Cowart B et al. The use of olfactory receptor neurons (ORNs) from biopsies to study changes in aging and neurodegenerative diseases. Ann N Y Acad Sci 1998;855:701-7
• Church AC, Bunney BS, Krieger NR. Neuronal localization of dopaminesensitive adenylate cyclase within the rat olfactory tubercle. Brain Res 1982;234: 369-76
• Baker H, Farbman AI. Olfactory afferent regulation of the dopamine phenotype in the fetal rat olfactory system. Neuroscience 1993;52:115-34
• Mijnster MJ, Isovich E, Flugge G et al. Localization of dopamine receptors in the tree shrew brain using 3H -SCH23390 and 125I -epidepride. Brain Res 1999;841: 101-13

Vancouver

Özdener MH, Rawson NE. OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES. EUR J GEN MED. 2004;1(3):1-11. https://doi.org/10.29333/ejgm/82202

APA

Özdener, M. H., & Rawson, N. E. (2004). OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES. European Journal of General Medicine, 1(3), 1-11. https://doi.org/10.29333/ejgm/82202

AMA

Özdener MH, Rawson NE. OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES. EUR J GEN MED. 2004;1(3), 1-11. https://doi.org/10.29333/ejgm/82202

Chicago

Özdener, M. Hakan, and Nancy E. Rawson. "OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES". European Journal of General Medicine 2004 1 no. 3 (2004): 1-11. https://doi.org/10.29333/ejgm/82202

Harvard

Özdener, M. H., and Rawson, N. E. (2004). OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES. European Journal of General Medicine, 1(3), pp. 1-11. https://doi.org/10.29333/ejgm/82202

MLA

Özdener, M. Hakan et al. "OLFACTORY DYSFUNCTION IN NEURODEGENERATIVE DISEASES". European Journal of General Medicine, vol. 1, no. 3, 2004, pp. 1-11. https://doi.org/10.29333/ejgm/82202